Search - tctmd.com

Displaying 921 - 940 of 2210

Sort: Relevancy | Date

News Daily News

CMR Confirms Link Between Moderate Aortic Regurgitation Post-TAVR and Poor Outcomes, Mortality

Yael L. Maxwell

August 05, 2016

News Daily News

Global Recall for Certain Lotus Valve Systems Following Reports of Death, Catastrophic Vessel Trauma

Michael H. Wilson

August 03, 2016

News Daily News

Next-Generation CoreValve Device Receives CE Mark for Use in Intermediate-Risk Patients

Todd Neale

August 01, 2016

News Daily News

TCTMD’s Top 10 Most Popular Stories for July 2016

Shelley Wood

July 28, 2016

News Industry News

Edwards Receives Approval For SAPIEN 3 Heart Valve In Canada

July 28, 2016

News Daily News

Blood Test May Be Useful for Detecting Aortic Regurgitation During TAVR

L.A. McKeown

July 27, 2016

News Daily News

简单风险评分系统预测 TAVR 后死亡率

Michael O'Riordan

July 25, 2016

News Daily News

Un Sistema Simple de Puntuación del Riesgo Predice la Mortalidad Post-TAVR

Michael O'Riordan

July 25, 2016

News Daily News

Simple Risk-Scoring System Predicts Mortality After TAVR

Michael O'Riordan

July 25, 2016

News Daily News

TAVR 后上消化道出血率高引发对抗血栓剂和 TEE 的质疑

Yael L. Maxwell

July 22, 2016

News Daily News

Los Altos Índices de Hemorragias Gastrointestinales Superiores Post-TAVR Plantean Dudas para los Antitrombóticos y ETE

Yael L. Maxwell

July 22, 2016

News Daily News

Minimally Invasive Mitral Valve Chordal Replacement Procedure Promising, but It’s Still Early Days

Shelley Wood

July 20, 2016

News Industry News

Essential Medical Inc. Announces CE Mark Approval for the MANTA™ Large Bore Vascular Closure Device

July 18, 2016

News Industry News

Mitralign Completes Enrollment in First Phase of US Early Feasibility Study on Tricuspid Repair

July 13, 2016

News Daily News

MAC 全球登记首次发表的报告强调了经导管二尖瓣置换的风险和机遇

Shelley Wood

July 11, 2016

News Daily News

First Published Report From MAC Global Registry Highlights Risks, Opportunities for Transcatheter Mitral Valve Replacement

Shelley Wood

July 11, 2016

News Daily News

El 1er Informe Publicado del Registro MAC Global Refleja los Riesgos y Oportunidades de la Sustitución de la Válvula Mitral Transcatéter

Shelley Wood

July 11, 2016

News Industry News

Essential Medical Inc. Announces FDA Approval to Begin a U.S. Clinical Trial for the MANTA™ Large Bore Vascular Closure Device

July 08, 2016

News Daily News

TAVR for Bicuspid Aortic Valve Stenosis Feasible, but Associated With Higher Rate of Permanent Pacemaker Implantation

Michael O'Riordan

July 05, 2016

News Daily News

TCTMD’s Top 10 Most Popular Stories for June 2016

Shelley Wood

July 01, 2016

Advertisement

CMR Confirms Link Between Moderate Aortic Regurgitation Post-TAVR and Poor Outcomes, Mortality

Global Recall for Certain Lotus Valve Systems Following Reports of Death, Catastrophic Vessel Trauma

Next-Generation CoreValve Device Receives CE Mark for Use in Intermediate-Risk Patients

TCTMD’s Top 10 Most Popular Stories for July 2016

Edwards Receives Approval For SAPIEN 3 Heart Valve In Canada

Blood Test May Be Useful for Detecting Aortic Regurgitation During TAVR

简单风险评分系统预测 TAVR 后死亡率

Un Sistema Simple de Puntuación del Riesgo Predice la Mortalidad Post-TAVR

Simple Risk-Scoring System Predicts Mortality After TAVR

TAVR 后上消化道出血率高引发对抗血栓剂和 TEE 的质疑

Los Altos Índices de Hemorragias Gastrointestinales Superiores Post-TAVR Plantean Dudas para los Antitrombóticos y ETE

Minimally Invasive Mitral Valve Chordal Replacement Procedure Promising, but It’s Still Early Days

Essential Medical Inc. Announces CE Mark Approval for the MANTA™ Large Bore Vascular Closure Device

Mitralign Completes Enrollment in First Phase of US Early Feasibility Study on Tricuspid Repair

MAC 全球登记首次发表的报告强调了经导管二尖瓣置换的风险和机遇

First Published Report From MAC Global Registry Highlights Risks, Opportunities for Transcatheter Mitral Valve Replacement

El 1er Informe Publicado del Registro MAC Global Refleja los Riesgos y Oportunidades de la Sustitución de la Válvula Mitral Transcatéter

Essential Medical Inc. Announces FDA Approval to Begin a U.S. Clinical Trial for the MANTA™ Large Bore Vascular Closure Device

TAVR for Bicuspid Aortic Valve Stenosis Feasible, but Associated With Higher Rate of Permanent Pacemaker Implantation

TCTMD’s Top 10 Most Popular Stories for June 2016

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content